Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company [Yahoo! Finance]
Oramed and Lifeward Announce Strategic Transaction
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Oramed Pharmaceuticals (NASDAQ:ORMP) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Oramed Reports Fiscal Third Quarter 2025 Financial Results [Yahoo! Finance]